
Thomas Brown
Examiner (ID: 11072)
| Most Active Art Unit | 2601 |
| Art Unit(s) | 2786, 2899, 2742, 2787, 2306, 2601, 2604, 2305, 2857 |
| Total Applications | 1242 |
| Issued Applications | 1062 |
| Pending Applications | 29 |
| Abandoned Applications | 151 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10220432
[patent_doc_number] => 20150105424
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-16
[patent_title] => 'SMALL VOLUME ORAL TRANSMUCOSAL DOSAGE FORMS CONTAINING SUFENTANIL FOR TREATMENT OF PAIN'
[patent_app_type] => utility
[patent_app_number] => 14/517260
[patent_app_country] => US
[patent_app_date] => 2014-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 21655
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14517260
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/517260 | Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain | Oct 16, 2014 | Issued |
Array
(
[id] => 9839623
[patent_doc_number] => 20150031705
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-29
[patent_title] => 'OPHTHALMIC FORMULATIONS INCLUDING SELECTIVE ALPHA 1 ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 14/513981
[patent_app_country] => US
[patent_app_date] => 2014-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 13366
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14513981
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/513981 | OPHTHALMIC FORMULATIONS INCLUDING SELECTIVE ALPHA 1 ANTAGONISTS | Oct 13, 2014 | Abandoned |
Array
(
[id] => 10000345
[patent_doc_number] => 09044418
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-06-02
[patent_title] => 'Treatment for depression and other mental conditions with synthetic isotope-modified lithium'
[patent_app_type] => utility
[patent_app_number] => 14/512292
[patent_app_country] => US
[patent_app_date] => 2014-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3175
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14512292
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/512292 | Treatment for depression and other mental conditions with synthetic isotope-modified lithium | Oct 9, 2014 | Issued |
Array
(
[id] => 10214771
[patent_doc_number] => 20150099763
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-09
[patent_title] => 'ITRACONAZOLE COMPOSITIONS AND DOSAGE FORMS, AND METHODS OF USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 14/511420
[patent_app_country] => US
[patent_app_date] => 2014-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 64
[patent_figures_cnt] => 64
[patent_no_of_words] => 60633
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14511420
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/511420 | Itraconazole compositions and dosage forms, and methods of using the same | Oct 9, 2014 | Issued |
Array
(
[id] => 10247385
[patent_doc_number] => 20150132381
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-14
[patent_title] => 'FORMULATIONS AND USES OF 2-HYDROXY-5-PHENYLAZOBENZOIC ACID DERIVATIVES FOR THE TREATMENT OF MALES'
[patent_app_type] => utility
[patent_app_number] => 14/509446
[patent_app_country] => US
[patent_app_date] => 2014-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11051
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14509446
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/509446 | FORMULATIONS AND USES OF 2-HYDROXY-5-PHENYLAZOBENZOIC ACID DERIVATIVES FOR THE TREATMENT OF MALES | Oct 7, 2014 | Abandoned |
Array
(
[id] => 11575717
[patent_doc_number] => 09630964
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-04-25
[patent_title] => 'Fluoro-9-methyl-β-carbolines'
[patent_app_type] => utility
[patent_app_number] => 15/025538
[patent_app_country] => US
[patent_app_date] => 2014-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 30
[patent_no_of_words] => 19090
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15025538
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/025538 | Fluoro-9-methyl-β-carbolines | Sep 28, 2014 | Issued |
Array
(
[id] => 9792306
[patent_doc_number] => 20150004250
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-01
[patent_title] => 'Topical formulations for the prevention of sexually transmitted disease and methods of producing the same'
[patent_app_type] => utility
[patent_app_number] => 14/486500
[patent_app_country] => US
[patent_app_date] => 2014-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3599
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14486500
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/486500 | Topical formulations for the prevention of sexually transmitted disease and methods of producing the same | Sep 14, 2014 | Abandoned |
Array
(
[id] => 9792307
[patent_doc_number] => 20150004251
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-01
[patent_title] => 'Topical formulations for the prevention of sexually transmitted disease and methods of producing the same'
[patent_app_type] => utility
[patent_app_number] => 14/486530
[patent_app_country] => US
[patent_app_date] => 2014-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4332
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14486530
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/486530 | Topical formulations for the prevention of sexually transmitted disease and methods of producing the same | Sep 14, 2014 | Abandoned |
Array
(
[id] => 10573019
[patent_doc_number] => 09295641
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-03-29
[patent_title] => 'Compositions containing alpha-2-adrenergic agonist components'
[patent_app_type] => utility
[patent_app_number] => 14/484017
[patent_app_country] => US
[patent_app_date] => 2014-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11759
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14484017
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/484017 | Compositions containing alpha-2-adrenergic agonist components | Sep 10, 2014 | Issued |
Array
(
[id] => 10975464
[patent_doc_number] => 20140378498
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-25
[patent_title] => 'Tamper Resistant Composition Comprising Hydrocodone And Acetaminophen For Rapid Onset And Extended Duration Of Analgesia'
[patent_app_type] => utility
[patent_app_number] => 14/479129
[patent_app_country] => US
[patent_app_date] => 2014-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 54740
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14479129
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/479129 | Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia | Sep 4, 2014 | Issued |
Array
(
[id] => 11023497
[patent_doc_number] => 20160220452
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-04
[patent_title] => 'POWDER MIXTURE, USE OF THE POWDER MIXTURE, AND A POWDER JET DEVICE'
[patent_app_type] => utility
[patent_app_number] => 15/022539
[patent_app_country] => US
[patent_app_date] => 2014-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3658
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15022539
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/022539 | Powder mixture, use of the powder mixture, and a powder jet device | Sep 1, 2014 | Issued |
Array
(
[id] => 12326076
[patent_doc_number] => 09944676
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-04-17
[patent_title] => Cationic lipid formulations for regressing established tumor
[patent_app_type] => utility
[patent_app_number] => 14/462880
[patent_app_country] => US
[patent_app_date] => 2014-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 24
[patent_no_of_words] => 10090
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14462880
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/462880 | Cationic lipid formulations for regressing established tumor | Aug 18, 2014 | Issued |
Array
(
[id] => 11935018
[patent_doc_number] => 20170239167
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-24
[patent_title] => 'Hair Products Containing Polyetheramine'
[patent_app_type] => utility
[patent_app_number] => 15/504669
[patent_app_country] => US
[patent_app_date] => 2014-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2044
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15504669
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/504669 | Hair Products Containing Polyetheramine | Aug 17, 2014 | Abandoned |
Array
(
[id] => 9839692
[patent_doc_number] => 20150031774
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-29
[patent_title] => 'RASAGILINE ORALLY DISINTEGRATING COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 14/458410
[patent_app_country] => US
[patent_app_date] => 2014-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8766
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14458410
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/458410 | RASAGILINE ORALLY DISINTEGRATING COMPOSITIONS | Aug 12, 2014 | Abandoned |
| 14/324192 | Oral delivery system for pazopanib hydrochloride | Jul 5, 2014 | Abandoned |
Array
(
[id] => 10911851
[patent_doc_number] => 20140314868
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-23
[patent_title] => 'PROSTAGLANDIN AND PROSTAMIDE DRUG DELIVERY SYSTEMS AND INTRAOCULAR THERAPEUTIC USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/323235
[patent_app_country] => US
[patent_app_date] => 2014-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11889
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14323235
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/323235 | Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof | Jul 2, 2014 | Issued |
Array
(
[id] => 12111798
[patent_doc_number] => 09867776
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-01-16
[patent_title] => 'Transdermal drug delivery system having multi-lamellar emulsion structure'
[patent_app_type] => utility
[patent_app_number] => 14/902102
[patent_app_country] => US
[patent_app_date] => 2014-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7061
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 153
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14902102
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/902102 | Transdermal drug delivery system having multi-lamellar emulsion structure | Jun 30, 2014 | Issued |
Array
(
[id] => 10154580
[patent_doc_number] => 09186330
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-11-17
[patent_title] => 'Sustained release formulation of nalbuphine'
[patent_app_type] => utility
[patent_app_number] => 14/319833
[patent_app_country] => US
[patent_app_date] => 2014-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 19562
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14319833
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/319833 | Sustained release formulation of nalbuphine | Jun 29, 2014 | Issued |
Array
(
[id] => 10902461
[patent_doc_number] => 20140305472
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-16
[patent_title] => 'CLEANING METHOD FOR A WORKING MECHANISM FOR MEDICAL MANIPULATOR'
[patent_app_type] => utility
[patent_app_number] => 14/317666
[patent_app_country] => US
[patent_app_date] => 2014-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 7846
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14317666
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/317666 | Cleaning method for a working mechanism for medical manipulator | Jun 26, 2014 | Issued |
Array
(
[id] => 9977040
[patent_doc_number] => 09023347
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-05-05
[patent_title] => 'L-lysine containing feed additives'
[patent_app_type] => utility
[patent_app_number] => 14/308086
[patent_app_country] => US
[patent_app_date] => 2014-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5748
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14308086
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/308086 | L-lysine containing feed additives | Jun 17, 2014 | Issued |